Cardiac involvement in Dengue Haemorrhagic Fever.
暂无分享,去创建一个
N. Wig | R. Handa | A Malhotra | V. Bahl | A. Biswas | J P Wali | A Biswas | S Chandra | P Aggarwal | R Handa | N Wig | V K Bahl | A. Malhotra | J. Wali | P. Aggarwal | S. Chandra
[1] S. Kabra,et al. Dengue haemorrhagic fever in children in Delhi. , 1992, Bulletin of the World Health Organization.
[2] H. Schultheiss,et al. Treatment of chronic myocarditis with corticosteroids. , 1995, European heart journal.
[3] A. Matsumori,et al. Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments. , 1995, European heart journal.
[4] Rehle Tm. Classification, distribution and importance of arboviruses. , 1989 .
[5] A. Sabin. Research on dengue during World War II. , 1952, The American journal of tropical medicine and hygiene.
[6] M. Sinniah,et al. Dengue haemorrhagic fever and dengue shock syndrome: are they tumour necrosis factor-mediated disorders? , 1991, FEMS microbiology immunology.
[7] M. Kazatchkine,et al. Pathogenesis of dengue: an alternative hypothesis. , 1990, The Southeast Asian journal of tropical medicine and public health.
[8] A. Nisalak,et al. Human immune responses to dengue viruses. , 1990, The Southeast Asian journal of tropical medicine and public health.
[9] S. Nimmannitya,et al. Clinical spectrum and management of dengue haemorrhagic fever. , 1987, The Southeast Asian journal of tropical medicine and public health.
[10] I. Kurane,et al. Immunity and immunopathology in dengue virus infections. , 1992, Seminars in immunology.
[11] M. Sharma,et al. Increased capillary permeability mediated by a dengue virus-induced lymphokine. , 1990, Immunology.
[12] S. Halstead,et al. Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. , 1989, Reviews of infectious diseases.
[13] F. Ennis,et al. Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity , 1989, The Journal of experimental medicine.
[14] R. Tan,et al. Some clinical and epidemiological observations on virologically confirmed dengue hemorrhagic fever. , 1990, Paediatrica Indonesiana.
[15] Y. A. Kasim,et al. Hyperventilation in children with dengue hemorrhagic fever (DHF). , 2019, Paediatrica Indonesiana.
[16] S. Halstead. The Alexander D. Langmuir Lecture. The pathogenesis of dengue. Molecular epidemiology in infectious disease. , 1981, American journal of epidemiology.
[17] S. Lam,et al. Dengue haemorrhagic fever , 1995 .
[18] M. Guzmán,et al. Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. , 1989, Bulletin of the World Health Organization.
[19] S. Jota,et al. Pericardial effusion in dengue haemorrhagic fever. , 2018, Paediatrica Indonesiana.
[20] R. Dhawan,et al. Effect of dengue virus-induced cytotoxin on capillary permeability. , 1990, Journal of experimental pathology.
[21] R. Dhawan,et al. Dengue virus‐induced human cytotoxic factor: production by peripheral blood leucocytes in vitro , 1995, Clinical and experimental immunology.
[22] S. Halstead,et al. Pathogenesis of dengue: challenges to molecular biology. , 1988, Science.
[23] A. Nisalak,et al. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. , 1991, The Journal of clinical investigation.
[24] D. Hober,et al. Serum Levels of Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and Interleukin-1β (IL-1β) in Dengue-Infected Patients , 1993 .
[25] M. Mirić,et al. Interferon and thymic hormones in the therapy of human myocarditis and idiopathic dilated cardiomyopathy. , 1995, European heart journal.
[26] Kim. PATHOGENESIS OF DENGUE. , 1988 .
[27] H. Schultheiss,et al. Immunohistochemistry in dilated cardiomyopathy. , 1995, European heart journal.